173 related articles for article (PubMed ID: 16053123)
21. [Clinical efficacy of activia tvorozhnaya in patients with the irritated bowels syndrome with the prevalence of constipations].
Parfenov AI; Ruchkina IN; Silvestrova SIu
Eksp Klin Gastroenterol; 2005; (3):37-42. PubMed ID: 16255551
[No Abstract] [Full Text] [Related]
22. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
Brenner DM; Chey WD
Rev Gastroenterol Disord; 2009; 9(1):7-15. PubMed ID: 19367213
[TBL] [Abstract][Full Text] [Related]
23. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
[TBL] [Abstract][Full Text] [Related]
24. [Irritable bowel syndrome. Reduction of symptoms, better quality of life].
MMW Fortschr Med; 2011 May; 153(19):52-3. PubMed ID: 21612101
[No Abstract] [Full Text] [Related]
25. Probiotics in functional gastrointestinal disorders: what are the facts?
Quigley EM
Curr Opin Pharmacol; 2008 Dec; 8(6):704-8. PubMed ID: 18775516
[TBL] [Abstract][Full Text] [Related]
26. Treatment of irritable bowel syndrome. A case control experience.
Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
[TBL] [Abstract][Full Text] [Related]
27. Bifidobacterium bifidum MIMBb75 in irritable bowel syndrome.
Quigley EM
Aliment Pharmacol Ther; 2011 Jul; 34(1):100-1; author reply 101. PubMed ID: 21631550
[No Abstract] [Full Text] [Related]
28. Probiotics in functional bowel disorders getting it right.
Quigley EM
J Clin Gastroenterol; 2011 Jul; 45(6):481-2. PubMed ID: 21617544
[No Abstract] [Full Text] [Related]
29. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
Colecchia A; Vestito A; La Rocca A; Pasqui F; Nikiforaki A; Festi D;
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):349-58. PubMed ID: 17108864
[TBL] [Abstract][Full Text] [Related]
30. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
[TBL] [Abstract][Full Text] [Related]
31. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome--a randomized controlled trial with primary care physicians.
Enck P; Zimmermann K; Menke G; Müller-Lissner S; Martens U; Klosterhalfen S
Neurogastroenterol Motil; 2008 Oct; 20(10):1103-9. PubMed ID: 18565142
[TBL] [Abstract][Full Text] [Related]
32. Oral probiotics prevent necrotizing enterocolitis.
Stricker T; Braegger CP
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):446-7. PubMed ID: 16641587
[No Abstract] [Full Text] [Related]
33. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
Quigley EM; Flourie B
Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
[TBL] [Abstract][Full Text] [Related]
34. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.
Sadrin S; Sennoune S; Gout B; Marque S; Moreau J; Zinoune K; Grillasca JP; Pons O; Maixent JM
Dig Liver Dis; 2020 May; 52(5):534-540. PubMed ID: 31952938
[TBL] [Abstract][Full Text] [Related]
35. [Clinical observation on acupuncture combined with microorganism pharmaceutical preparations for treatment of irritable bowel syndrome of constipation type].
Long ZR; Yu CH; Yang Y; Wang HN; Chi XX
Zhongguo Zhen Jiu; 2006 Jun; 26(6):403-5. PubMed ID: 16813181
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
Parkes GC; Brostoff J; Whelan K; Sanderson JD
Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
Nikfar S; Rahimi R; Rahimi F; Derakhshani S; Abdollahi M
Dis Colon Rectum; 2008 Dec; 51(12):1775-80. PubMed ID: 18465170
[TBL] [Abstract][Full Text] [Related]
38. Probiotics in the treatment of irritable bowel syndrome.
Saggioro A
J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S104-6. PubMed ID: 15220671
[TBL] [Abstract][Full Text] [Related]
39. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants.
Kliegman RM
J Pediatr; 2005 May; 146(5):710. PubMed ID: 15870682
[No Abstract] [Full Text] [Related]
40. Good bacteria for GI disorders.
Johns Hopkins Med Lett Health After 50; 2006 Jan; 17(11):1-2, 6. PubMed ID: 16444829
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
